Clinical Trial Update: Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP) [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial in familial adenomatous polyposis (Adenomatous Polyposis Coli) was terminated; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenomatous Polyposis Coli
• Familial Adenomatous Polyposis

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Adenomatous Polyposis Coli | Phase 3 | Status: TERMINATED | Results posted: 2014-11-03